Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications

被引:12
作者
Bashir, Mohammad [1 ]
Elhadd, Tarik [1 ,2 ]
Dabbous, Zeinab [1 ]
Gul, Wajiha [1 ]
Salameh, Obada [1 ]
Siddiqui, Mashhood [1 ]
Al-Muhannadi, Hamad [3 ]
Petropoulos, Ioannis [3 ]
Khan, Adnan [3 ]
Ponirakis, Georgios [3 ]
Malik, Rayaz A. [3 ,4 ]
机构
[1] Hamad Gen Hosp, Hamad Med Corp, Natl Diabet & Endocrine Ctr, Doha, Qatar
[2] Al Wakra Hosp, Hamad Med Corp, Natl Diabet & Endocrine Ctr, Doha, Qatar
[3] Weill Cornell Med Qatar, Qatar Fdn, POB 24144, Doha, Qatar
[4] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England
关键词
Diabetic neuropathy; Retinopathy; Microalbuminuria; Type; 2; diabetes; Glycemia; Blood pressure; Lipids; MULTIFACTORIAL INTERVENTION; NEUROPATHIC PAIN; GLUCOSE CONTROL; RISK-FACTORS; MELLITUS; PROGRESSION; THERAPIES; MORTALITY; OUTCOMES; DN4;
D O I
10.1016/j.dsx.2021.102241
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetic microvascular complications are a major cause of morbidity and are related to glycaemic control and cardiovascular risk factors. Aims: We sought to determine the association of microvascular complications in relation to control of glycemia, blood pressure and lipids in T2DM patients attending secondary care in Qatar. Methods: This is a cross-sectional study undertaken in patients with T2DM attending Qatar's National Diabetes Centres. Patients underwent assessment of glycemia, blood pressure and lipids and prevalence of diabetic peripheral neuropathy (DPN), retinopathy and microalbuminuria. Results: We included 1114 subjects aged 52.1 +/- 11.3 years with a duration of diabetes 10.0 +/- 7.6 years and had a prevalence of 25.8% for DPN, 34.3% for painful DPN, 36.8% for microalbuminuria and 25.1% for retinopathy. Patients who achieved an HbA1c <= 7.0% compared to >7% had a significantly lower prevalence of DPN (P < 0.01), painful DPN (P < 0.01), retinopathy (P < 0.01) and microalbuminuria (P < 0.007). Patients who achieved a systolic BP <= 140 mmHg compared to >140 mmHg had a significantly lower prevalence of DPN (P < 0.001), painful DPN (P < 0.001), retinopathy (P < 0.001) and microalbuminuria (P < 0.001). Patients who achieved an LDL <= 2.6 mmol/l compared to >2.6 mmol/l had a significantly higher prevalence of DPN (P < 0.03), but no difference in other outcomes. There was no difference in microvascular complications between those who achieved a HDL-C >= 1.02 mmol/l, and among those who achieved triglycerides <= 1.7 mmol/l. Conclusions: Optimal control of glycemia and blood pressure, but not lipids is associated with a lower prevalence of diabetic microvascular complications. (C) 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页数:6
相关论文
共 47 条
[11]   Effect of a multifactorial intervention on mortality in type 2 diabetes [J].
Gaede, Peter ;
Lund-Andersen, Henrik ;
Parving, Hans-Henrik ;
Pedersen, Oluf .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) :580-591
[12]   Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial [J].
Gde, Peter ;
Oellgaard, Jens ;
Carstensen, Bendix ;
Rossing, Peter ;
Lund-Andersen, Henrik ;
Parving, Hans-Henrik ;
Pedersen, Oluf .
DIABETOLOGIA, 2016, 59 (11) :2298-2307
[13]   Statin Therapy Reduces Future Risk of Lower-Limb Amputation in Patients With Diabetes and Peripheral Artery Disease [J].
Hsu, Chien-Yi ;
Chen, Yung-Tai ;
Su, Yu-Wen ;
Chang, Chun-Chin ;
Huang, Po-Hsun ;
Lin, Shing-Jong .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (07) :2373-2381
[14]   Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial [J].
Ismail-Beigi, Faramarz ;
Craven, Timothy ;
Banerji, Mary Ann ;
Basile, Jan ;
Calles, Jorge ;
Cohen, Robert M. ;
Cuddihy, Robert ;
Cushman, William C. ;
Genuth, Saul ;
Grimm, Richard H., Jr. ;
Hamilton, Bruce P. ;
Hoogwerf, Byron ;
Karl, Diane ;
Katz, Lois ;
Krikorian, Armand ;
O'Connor, Patrick ;
Pop-Busui, Rodica ;
Schubart, Ulrich ;
Simmons, Debra ;
Taylor, Harris ;
Thomas, Abraham ;
Weiss, Daniel ;
Hramiak, Irene .
LANCET, 2010, 376 (9739) :419-430
[15]   Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan [J].
Lin, Ying-Chieh ;
Chen, Yu-Ching ;
Horng, Jorng-Tzong ;
Chen, Jui-Ming .
MEDICINA-LITHUANIA, 2020, 56 (08) :1-10
[16]   Hypertension, blood pressure control and diabetic retinopathy in a large population-based study [J].
Liu, Lei ;
Nguyen Duc Quang ;
Banu, Riswana ;
Kumar, Himeesh ;
Yih-Chung Tham ;
Cheng, Ching-Yu ;
Wong, Tien Yin ;
Sabanayagam, Charumathi .
PLOS ONE, 2020, 15 (03)
[17]   Wherefore Art Thou, O Treatment for Diabetic Neuropathy? [J].
Malik, R. A. .
CONTROVERSIES IN DIABETIC NEUROPATHY, 2016, 127 :287-317
[18]   Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: Randomised doubleblind controlled trial [J].
Malik, RA ;
Williamson, S ;
Abbott, C ;
Carrington, AL ;
Iqbal, J ;
Schady, W ;
Boulton, AJM .
LANCET, 1998, 352 (9145) :1978-1981
[19]   Why are there no good treatments for diabetic neuropathy? [J].
Malik, Rayaz A. .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (08) :607-609
[20]  
Marvin Moser, 1999, J CLIN HYPERTENS, V1, P48